These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5306518)

  • 1. [Determination of tissue penetrability and therapeutic dose of epsilon-aminocaproic acid, AMCHA and trasylol with the help of direct homogenate- plasma-thromboelastography examplified on the fibrinolytically active myometrium].
    Schmidt-Matthiesen H; Schreinert B
    Klin Wochenschr; 1968 Jul; 46(13):730-1. PubMed ID: 5306518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid)].
    Marmo E; Ungaro B; Giordano L
    Minerva Cardioangiol; 1971 Feb; 19(2):86-115. PubMed ID: 4396734
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of antifibrinolytic substances on allergic reactions. Experiments with epsilon-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid.
    Raab W
    Experientia; 1968 Mar; 24(3):250. PubMed ID: 5661420
    [No Abstract]   [Full Text] [Related]  

  • 5. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of AMCHA. (A comparative study with epsilon-aminocaproic acid).
    Melander B; Gliniecki G; Granstrand B; Hanshoff G
    Acta Pharmacol Toxicol (Copenh); 1965; 22(4):340-52. PubMed ID: 5898250
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of trans-AMCHA (trans-aminomethylcyclohexanecarboxylic acid) on fibrinolytic activity].
    Leube G; Kuehn JJ
    Med Welt; 1969 Aug; 34():1846-50. PubMed ID: 4185877
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of antifibrinolytic drugs.
    Marmo E; Di Nola R; Rossi F
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):137-50. PubMed ID: 4542597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

  • 12. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intestinal absorption, distribution and elimination of 4-aminomethylcyclohexanecarboxylic acid (AMCHA) and epsilon-aminocaproic acid (ACA) in humans].
    Kaller H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):160-8. PubMed ID: 4232998
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of antifibrinolytic agents on wound healing.
    Björlin G; Nilsson IM
    Int J Oral Maxillofac Surg; 1988 Aug; 17(4):275-6. PubMed ID: 3139802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents].
    Giacomazzi G
    Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifibrinolytic additives to fibrin glue for laparoscopic wound closure in urinary tract.
    Beduschi R; Beduschi MC; Wojno KJ; Jhung M; Williams AL; Wolf JS
    J Endourol; 1999 May; 13(4):283-7. PubMed ID: 10405907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies on inhibitors of fibrinolysis in vitro and in vivo.
    Deutsch E; Fischer M
    Acta Haematol; 1968; 39(1):1-12. PubMed ID: 4968865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolism of fibrinogen following administration of brain phospholipids in combination with an antifibrinolytic agent (AMCHA)].
    Cultrera G; Lampugnani P
    Arzneimittelforschung; 1973 Mar; 23(3):445-7. PubMed ID: 4740135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.